Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,642
datasets available to search
ShareScore release 0.9.0
Dataset results
2,642 results for “blindness”
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
ClinicalTrials.gov study NCT06444048. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)
ClinicalTrials.gov study NCT01228747. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test
ClinicalTrials.gov study NCT00883103. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Sev
ClinicalTrials.gov study NCT03390101. IPD Sharing: NO. Countries: 1. Publications: 1.
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
ClinicalTrials.gov study NCT00785629. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in
ClinicalTrials.gov study NCT01539642. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02370238. IPD Sharing: NO. Countries: 7. Publications: 2.
A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy
ClinicalTrials.gov study NCT00477295. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial
ClinicalTrials.gov study NCT04448028. IPD Sharing: YES. Countries: 1. Publications: 1.
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
ClinicalTrials.gov study NCT00994175. IPD Sharing: YES. Countries: 1. Publications: 4.
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
ClinicalTrials.gov study NCT00687713. IPD Sharing: NO. Countries: 1. Publications: 1.
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Prot
ClinicalTrials.gov study NCT03952650. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
ClinicalTrials.gov study NCT04094662. IPD Sharing: YES. Countries: 1. Publications: 1.
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01322490. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Young Blind Child Melatonin Treatment Study
ClinicalTrials.gov study NCT00688935. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
ClinicalTrials.gov study NCT02452476. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
ClinicalTrials.gov study NCT04625972. IPD Sharing: YES. Countries: 2. Publications: 10.
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01241591. IPD Sharing: Not stated. Countries: 26. Publications: 3.
Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial
ClinicalTrials.gov study NCT02013427. IPD Sharing: NO. Countries: 1. Publications: 3.
Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study
ClinicalTrials.gov study NCT02907268. IPD Sharing: YES. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.